Star Therapeutics gets $200M to try repeating its Vega, Electra successes
Star Therapeutics has collected $200 million to see whether its homegrown research can produce a new pipeline of medicines after prior successes that have been shipped elsewhere. The new capital is essentially a fresh start ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.